News + Filings Transactions Holdings
|
WELLINGTON MANAGEMENT GROUP LLP
> VERV
Date | Name | Ticker | Shares | Change | Value | Change | Price |
06/30/2023 | Verve Therapeutics, Inc. | VERV | 976,128 | 42,961 | 18,302,400,000 | 4,846,131,000 | $18,750.00 |
03/31/2023 | Verve Therapeutics, Inc. | VERV | 933,167 | -77,541 | 13,456,269,000 | 13,421,551,000 | $14,420.00 |
09/30/2022 | Verve Therapeutics, Inc. | VERV | 1,010,708 | -252,676 | 34,718,000 | 15,413,000 | $34.35 |
06/30/2022 | Verve Therapeutics, Inc. | VERV | 1,263,384 | -1,082,663 | 19,305,000 | -34,233,000 | $15.28 |
03/31/2022 | Verve Therapeutics, Inc. | VERV | 2,346,047 | -1,593,461 | 53,538,000 | -91,713,000 | $22.82 |
12/31/2021 | Verve Therapeutics, Inc. | VERV | 3,939,508 | -654,718 | 145,251,000 | -68,300,000 | $36.87 |
09/30/2021 | Verve Therapeutics, Inc. | VERV | 4,594,226 | 628,747 | 213,551,000 | -18,531,000 | $46.48 |
06/30/2021 | Verve Therapeutics, Inc. | VERV | 3,965,479 | 3,965,479 | 232,082,000 | 232,082,000 | $58.53 |
<< Prev Next >> |
|